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Natural killer (NK) cells are a subset of immune effec-
tors that directly bind and kill fungi via a perforin-
dependent mechanism. The receptor mediating this
activity and its potential role in disease remain un-
known. Using an unbiased approach, we determined
that NKp30 is responsible for recognition and killing
of the fungal pathogens Cryptococcus and Candida.
NKp30 was required for NK cell-fungal conju-
gate formation, phosphatidylinositol 3-kinase (PI3K)
signaling, and perforin release. Because fungal infec-
tions are a leading cause of death in AIDS patients,
we examined NKp30 expression in HIV-infected
patients. NK cells from these patients had dimin-
ished NKp30 expression, defective perforin release,
and blunted microbicidal activity. Surprisingly, inter-
leukin-12 (IL-12) restored NKp30 expression and
fungal killing. Thus, the NKp30 receptor plays a
critical role in NK cell antifungal cytotoxicity, and
diminished expression of NKp30 is responsible for
defective antifungal activity of NK cells from HIV-
infected patients, which can be corrected with IL-12.
INTRODUCTION
NK cells directly recognize and kill microbes in addition to killing
tumor and virus-infected cells. These microbicidal NK cells are
active against a wide variety of pathogens, including fungi
such as C. neoformans and C. albicans (Beno and Mathews,
1990; Hidore et al., 1991b; Levitz et al., 1994; Nabavi and Mur-
phy, 1985). NK cell-mediated killing of C. neoformans requires
a discrete binding event (Hidore et al., 1991a; Murphy et al.,
1993), leading to signaling via the phosphatidylinositol 3-kinaseCell Host(PI3K)-ERK1/ERK2 pathway (Wiseman et al., 2007). Signaling
leads to the formation of a microbial synapse between the NK
cell and the pathogen that precedes lytic degranulation, which
provides the effector molecule, perforin, for anticryptococcal
activity (Ma et al., 2004). A number of studies have suggested
a receptor in NK cell recognition of the microbes; however, the
receptor had not been identified.
To identify the receptor used by NK cells to recognize and
kill fungi, a large array of NK cell receptors for microbial recogni-
tion and activation needed to be considered. NK cells express
pattern recognition receptors such as toll-like receptors,
C-type lectin receptors, and complement and scavenger recep-
tors that function in innate recognition of fungi (Braun et al., 2011;
Chalifour et al., 2004; Kato et al., 2006). These receptors regulate
immunity and modulate cytotoxicity to tumor and virus-infected
cells but have not been shown to directly trigger a cytolytic
pathway (Baratin et al., 2005; Sivori et al., 2004). By contrast,
the known NK activating receptors that recognize tumor or
virus-infected cells consist of four families, including natural
killer group 2 (NKG2), natural cytotoxicity receptors (NCR), the
noninhibitory killer inhibitor receptors (KIR), and the signaling
lymphocyte activation molecule (SLAM) family (Biassoni, 2008;
Campbell and Purdy, 2011; Cannons et al., 2011). However,
despite their known functions in cytotoxicity of tumor and
virus-infected cells, none of these receptors have been impli-
cated in recognition of fungi. For this reason, we employed an
unbiased systematic screen to identify the fungal receptor
used for direct cytotoxicity.
Opportunistic fungi, such as Cryptococcus neoformans, are
among the most devastating complications that afflict AIDS
patients (Coker, 1992; Dismukes, 1988). C. neoformans causes
pneumonia and meningoencephalitis that is uniformly fatal
without treatment (Perfect et al., 2010). Recently, it has been
estimated that almost a million cases of cryptococcal meningitis
occur among AIDS patients per year, and two thirds of these
people die within 3months of diagnosis (Park et al., 2009). Unfor-
tunately, even with active therapy, those that survive often have& Microbe 14, 387–397, October 16, 2013 ª2013 Elsevier Inc. 387
Figure 1. Identification of NKp30 as the NK
Cell Fungicidal Receptor
(A) YT cells were pretreated with mAb 1C01 or
control mouse IgG. C. neoformans was added to
the cultures, and colony-forming units (cfu) were
determined 24 hr later. *p < 0.01; data are repre-
sented as mean ± SEM; NS, not significant.
(B) YT cells were surface biotinylated, and the
proteins were purified using streptavidin-bound
beads. Increasing amounts of protein were loaded
and resolved in an SDS-PAGE gel. After transfer,
the membrane was blotted with mAb 1C01. M:
protein marker.
(C) Colocalization of molecules recognized by
mAb 1C01 and a polyclonal anti-NKp30 antibody.
Increasing amounts of YT cell (403 106/ml) lysate
were resolved in SDS-PAGE gel and blotted
simultaneously with mAb 1C01 and rabbit anti-
NKp30 antibodies revealed by antibodies emitting
different infrared (IR) spectra.
(D) Reciprocal recognition of immunoprecipitates
(IP) with mAb 1C01 or anti-NKp30 antibody. The
nitrocellulose membrane was immunoblotted
(IB) and cross-blotted with 1C01 or anti-NKp30.
Experiments in (A–D) were repeatedR4 timeswith
similar results.
(E) Immunoblot analysis of NKp30 knockdown in
YT cells. Data shown are representative of three
experiments. siRNAC: control siRNA; siRNA3,
siRNA4, and siRNA5: target-specific sequences of
siRNA for human NKp30. See also Figure S1.
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kins, 2010; Montessori et al., 2004). Additionally, other more
prevalent, but less-devastating, opportunistic fungi such as
Candida albicans cause AIDS-defining oral and esophageal
infections (Klein et al., 1984).
Defective NK cell function contributes to the immunosuppres-
sion in HIV-infected patients, leading to opportunistic infec-
tions. The mechanisms by which HIV causes NK cell dysfunction
include dysregulated production of cytokines, altered expres-
sion of NK cell receptors, and defects in the NK cell lytic
machinery and microtubule rearrangement that is necessary
for cytolytic granule polarization and cytotoxicity (Alter et al.,
2005; Iannello et al., 2008; Mavilio et al., 2005; Sirianni et al.,
1988). It was not clear whether defective recognition of fungi
might contribute to reduced fungal killing by NK cells from HIV-
infected patients or whether this defect might be reversible.
To identify the NK receptor used to kill C. neoformans and
study the role of the receptor in the pathogenesis of cryptococcal
infection in HIV-infected patients, we used an unbiased system-
atic approach by generating a panel of mouse monoclonal
antibodies to human NK cells and screened for their ability to
block NK cell binding to Cryptococcus using flow cytometric
analysis. We identified the receptor and characterized it
as the key molecule needed for recognition and killing of
C. neoformans. We went on to demonstrate that expression of388 Cell Host & Microbe 14, 387–397, October 16, 2013 ª2013 Elsevier Inc.this receptor is reduced on NK cells
from HIV-infected patients, leading to
defective anticryptococcal cytotoxicity.
Most importantly, we translated thesefindings to demonstrate that treatment with IL-12 restored re-
ceptor expression on NK cells from HIV-infected patients and
enhanced anticryptococcal activity.
RESULTS
Identification of NKp30 as the NK Cell Fungicidal
Receptor
We generated a panel of monoclonal antibodies to NK cells. To
do this, we immunized mice with YT cells, a human leukemic
NK cell line capable of killing C. neoformans. Among 2,680
hybridoma clones, 99 clones that produced antibodies with
high binding capacity to YT cells (Figure S1A, available online)
were further screened for their ability to inhibit YT cell anticryp-
tococcal activity (Figure S1B). This revealed a monoclonal anti-
body, 1C01 (isotype IgG2a, k), that significantly inhibited YT
cell killing of C. neoformans (Figure 1A).
By examining surface biotinylated proteins of YT cells, we
were able to demonstrate that the protein recognized by 1C01
migrated as a single band in SDS-PAGE, with an apparent
molecular weight of 27–30 kDa (Figure 1B). A similar band was
also identified using whole-cell lysates (Figures S1C and S1D).
Since 1C01 recognized and masked an activating receptor
that migrated at 27–30 kDa, we asked whether 1C01 might
recognize NKp30. NKp30 is a NK cell-activating receptor with
Figure 2. Expression of NKp30 on YT Cells
and Primary NK Cells
(A–E) Labeling with mAb 1C01 of YT cells (A) or
purified primary NK cells (B) and analyzed by flow
cytometry. Labeling with a commercial rabbit
polyclonal anti-NKp30 antibody of YT cells (C) or
purified primary NK cells (D) and analyzed by flow
cytometry. Labeling of YT cells with mAb 1C01
and analyzed by immunofluorescencemicroscopy
(E). Scale bar = 10 mm. Purified human primary NK
cells were from healthy donors (CD3CD16+
CD56+; n = 3).
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tumor cells (Pende et al., 1999). A two-color imaging system
showed that the bands visualized by monoclonal antibody
(mAb) 1C01 and the major band revealed by a commercial poly-
clonal anti-NKp30 antibody colocalized (Figure 1C) and that
these antibodies cross-reacted with reciprocal immunoprecipi-
tates (Figure 1D), providing strong evidence that mAb 1C01
recognized NKp30. To confirm this result, we used siRNA to
knock down natural cytotoxicity-triggering receptor 3 (NCR3,
the gene that encodes NKp30) in YT cells and assessed
NKp30 by immunoblot using mAb 1C01 or the commercial
anti-NKp30 Ab. Two different siRNA sequences (siRNA4 and
siRNA5) reduced NKp30 protein expression, as determined by
immunoblot with 1C01 and anti-NKp30 antibodies, while control
siRNAc and a third siRNA (siRNA3) had no effect (Figure 1E).
These data confirmed that the molecule recognized by mAb
1C01 was NKp30.
NKp30 Expression Pattern on the Surface of YT Cells
and Primary NK Cells
We used mAb 1C01 and the commercial anti-NKp30 antibody to
profile its surface expression pattern in NK cells. Flow cytometry
analysis showed strong fluorescence intensities on YT cells (Fig-
ure 2A) and primary NK cells (Figure 2B) with mAb 1C01 labeling.Cell Host & Microbe 14, 387–397,The commercial anti-NKp30 antibody
confirmed that YT cells (Figure 2C), like
human primary NK cells, expressed the
NKp30 receptor (Figure 2D) (Hsieh et al.,
2006; Marcenaro et al., 2003). Immuno-
fluorescence microscopy showed a
discontinuous linear pattern of surface la-
beling on YT cells (Figure 2E).
The NKp30 Receptor Mediated
Conjugate Formation between YT
Cells and C. neoformans
To kill C. neoformans, NK cells need to
bind, form a conjugate with, and polarize
to the organism (Murphy et al., 1991;
Murphy et al., 1993). We performed ex-
periments to assess whether a ligand on
the surface of C. neoformans binds to
NKp30 in YT cells. We pretreated YT cells
with a preparation of the cryptococcal
cell wall/membrane (CCW/M) (Modyet al., 1996) and labeled YT cells with mAb 1C01. Flow cytomet-
ric analyses showed that CCW/M produced a dose-dependent
decrease in mAb 1C01 binding to YT cells, as reflected by a
reduction in mean fluorescence intensity (MFI) (Figure 3A), sug-
gesting that a ligand in the cell wall from C. neoformans
competed for binding of 1C01 to NKp30.
We performed experiments to test whether NKp30 mediates
YT cell conjugate formation with C. neoformans. We labeled
YT cells with tetramethylrhodamine-5(and -6)-isothiocyanate
(TRITC) and C. neoformans with fluorescein isothiocyanate
(FITC) and mixed and incubated them in the presence of
mAb 1C01 or control immunoglobulin G (IgG). The mAb 1C01
inhibited conjugate formation by 38%, as quantified by flow
cytometry (Figure 3B), indicating that mAb 1C01 masked the
NKp30 receptor used to recognize C. neoformans and form a
conjugate.
To determine whether the NKp30 receptor polarizes to the
synapse between YT and C. neoformans, we cocultured YT cells
with C. neoformans and labeled with mAb 1C01, anti-perforin-
FITC, and phalloidin-A 633, which labels F-actin. Fluorescence
microscopy showed that NKp30 polarized to the microbial syn-
apse together with perforin and F-actin, suggesting that the
NKp30 receptor was part of the structure forming the NK-micro-
bial synapse (Figure 3C).October 16, 2013 ª2013 Elsevier Inc. 389
Figure 3. NKp30BoundC. neoformans andMediatedNKCell-Micro-
bial Synapse Formation
(A) A ligand fromCryptococcus competed for binding of mAb 1C01 to YT cells.
YT cells were pretreated with various amounts (0, 10, and 30 ml) of CCW/M
(334.1 mg/ml of protein) before labeling with mAb 1C01 and flow cytometric
analysis. Data shown are representative of three experiments. MFI: mean
fluorescence intensity.
(B) mAb 1C01 inhibited conjugates between YT cells and Cryptococcus.
TRITC-labeled YT cells were preincubated with mAb 1C01 or control Ab prior
to adding FITC-labeled C. neoformans. Conjugates were detected when both
red and green were detected in the same event by flow cytometry. Data shown
are representative of four experiments.
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NK Fungal Cytotoxicity
We previously showed that NK cell anticryptococcal activity is
mediated via a PI3K-ERK signaling pathway (Wiseman et al.,
2007). Having shown that the NKp30 receptor is used to recog-
nize and form conjugates with Cryptococcus, we asked whether
the antibody might disrupt intracellular signaling. We cultured YT
cells with C. neoformans in the presence of mAb 1C01 or control
IgG and examined phosphorylation of Akt (reflecting PI3K activa-
tion), ERK1, and ERK2. YT cells that had been stimulated with
C. neoformans demonstrated an increased phosphorylation of
Akt, ERK1, and ERK2 at 5 min that was inhibited by mAb 1C01
(Figure 4A). This observation shows that NKp30 was involved
in cellular signaling, which is required for NK cell microbicidal
activity.
The NKp30 Receptor Mediated Perforin Release from
NK Cells
Since perforin is the effector molecule used by NK cells for cryp-
tococcal killing (Ma et al., 2004), we were interested to know
whether NKp30 mediates perforin release. We examined the
ability of mAb 1C01 to block perforin release in response to
C. neoformans by measuring the concentrations of perforin in
culture media by ELISA. We pretreated YT cells or primary NK
cells with mAb 1C01 or isotype-matched Ab for 30 min before
coculture with C. neoformans and for various times afterward.
The perforin released into the culture media was decreased
when mAb 1C01-treated YT cells (Figure 4B) or human primary
NK cells (Figure 4C) were compared with cells pretreated with
control IgG. Additionally, YT cells pretreated with mAb 1C01
retained more intracellular perforin than cells pretreated with
control IgG did, as assessed by immunoblot analysis (Figure 4D).
In addition, siRNA knockdown of NKp30 resulted in decreased
release of perforin following exposure to C. neoformans, as
shown by ELISA (Figure S2). Similar results were also observed
at the single-cell level in YT cells and primary NK cells by flow
cytometric analysis (data not shown). Taken together, these
results indicated that the NKp30 receptor mediated perforin
release in response to C. neoformans.
The NKp30 Receptor Was Required for YT Cell Fungal
Cytotoxicity
These results provide evidence that NKp30 is required for NK cell
fungal cytotoxicity. To determine whether the NKp30 receptor is
required for the killing of C. neoformans, we performed knock-
down of NKp30 in YT cells prior to assessing antifungal activity.
Treatment with two different siRNAs that knocked down NKp30
expression (siRNA4 and siRNA5; Figure 1E) resulted in a dimin-
ished capacity of YT cells to kill both C. neoformans (Figure 5A)
and Candida albicans (Figure 5B), while a control siRNA and an
ineffective siRNA (siRNA3) did not block the antifungal activity.
We also performed experiments to test whether an anti-NKp30
antibody could block YT fungal cytotoxicity. YT cells pretreated(C) The NKp30 receptor localized at the YT-microbe synapse. YT cells and
C. neoformans (strain B3501) were coincubated for 4 hr and labeled with mAb
1C01 (Alexa 555, red), anti-perforin Ab (FITC, green), and phalloidin, which
labels F-actin (A633-Cy5, blue). Data shown are representative of multiple
conjugates in two experiments. Scale bar = 10 mm.
ier Inc.
Figure 4. The NKp30 Receptor Mediated
Cellular Signaling and Perforin Release
from NK Cells
(A) mAb 1C01 inhibited PI3K and Erk signaling. YT
cells were cultured with or without C. neoformans
(B3501) in the presence of mAb 1C01 (25 mg/ml) or
control IgG. Proteins in the YT lysatewere resolved
in SDS-PAGE gels and blotted with anti-phospho-
Akt1/2/3 (Ser473), or anti-phospho-ERK. Data
shown are representative of three experiments.
(B andC)mAb 1C01 inhibited perforin release from
YTcells andprimaryNKcells. Perforin in the culture
media from YT cells (B) or human primary NK cells
(C) stimulated with C. neoformans in the presence
of 1C01 or control was assessed using ELISA.
Experiments (B) and (C) were repeated twice with
similar results. Statistics: t test (one-tailed). Data
are represented as mean ± SEM; *p < 0.05.
(D) Immunoblot analysis of perforin in YT cells. YT
cells (0.5 3 105/well) were pretreated with mAb
1C01 (25 mg/ml) or isotype-matched Ab in condi-
tioned medium for 30 min followed by coculture
with C. neoformans (B3501) for the indicated
times. The time point 0.5 hr indicates cells
before pretreatment with mAb 1C01, and 0.5 hr,
etc. indicate incubation time with C neoformans
(strain B3501). Experiments were repeated three
times with similar results. b-actin was used to
assess equivalent loading in each well. See also
Figure S2.
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including serotype D of C. neoformans encapsulated strain
B3501 (Figure 5C), acapsular strain CAP67 (Figure 5D), serotype
A encapsulated strain H99 (Figure 5E), and C. albicans (strain
LUMC 101; Figure 5F). Anti-Candida activity was confirmed by
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium (MTS) measurement, which as-
sesses metabolic activity rather than numbers or colony-forming
units (cfu; Figure S3A). Together, these data indicated that the
NKp30 receptor was required for NK cell killing of fungi.
Additional experiments were performed to examine the effect
of capsule induction on NKp30-mediated YT killing. For this pur-
pose, C. neoformans was cultured in the presence of an iron
chelator, desferoxamine, to enhance capsule formation (Varti-
varian et al., 1993). YT cells were able to kill strain B3501 with
enhanced capsule (Figure S3B), and mAb 1C01 was able to
block this killing (Figure S3C). Since NKp30 is required for killing
of encapsulated and acapsular strains of C. neoformans as well
as Candida albicans, it suggests that a common fungal ligand is
shared among these microbes. These findings would be most
consistent with a ligand in the cell wall rather than a capsular
antigen.
NK Cells from HIV-Infected Patients Had Defective
NKp30 Expression and Fungal Cytotoxicity
HIV/AIDS patients, who are at an increased risk of developing
cryptococcosis, have defective NK cell function and impaired
clearance of C. neoformans by NK cells (Horn and Washburn,
1995; Park et al., 2009). Consequently, we were interested in
knowing whether NKp30 plays a role in microbicidal activity in
these patients. Primary NK cells from HIV-infected patients
had modest but significantly lower levels of NKp30 fluorescenceCell Hostas compared to healthy adults tested in paired comparison as
shown by labeling with mAb 1C01 and the anti-NKp30 antibody
(Figure 6A). Previous studies demonstrated that decreased
expression of NKp30 correlated with reduced tumor cytotoxicity
(Sivori et al., 2000); thus, we sought to determine whether the
reduced expression of NKp30 on NK cells from HIV-infected
subjects correlated with a reduced ability to kill C. neoformans.
Compared to healthy adults, NK cells from HIV-infected patients
failed to demonstrate significant anticryptococcal activity (Fig-
ure 6B). Moreover, the reduction in anticryptococcal activity
correlated with significantly lower levels of perforin detected in
the culture media of NK cells and C. neoformans from HIV-
infected patients compared to healthy subjects (Figure 6C).
Thus, NK cells from HIV-infected subjects have reduced expres-
sion of the NKp30 receptor, reduced perforin release in response
to Cryptococcus, and reduced cryptococcal killing.
The Defective NKp30 Expression and Fungal
Cytotoxicity Can Be Restored by Interleukin-12 in NK
Cells from HIV-Infected Patients
In light of the reduced antifungal activity of NK cells from HIV-in-
fected persons, we sought to determine whether the defective
NKp30 expression and anticryptococcal activity might be
reversible. Since IL-12 has been shown to augment the anticryp-
tococcal activity of NK cells fromHIV-infected patients (Horn and
Washburn, 1995), we asked whether IL-12 could stimulate
NKp30 expression on NK cells from HIV-infected patients and
whether that would increase the ability to kill Cryptococcus. To
answer these questions, we cocultured NK cells from healthy do-
nors and HIV-infected patients with recombinant IL-12 for 24 hr
and assessed NKp30 expression. Flow cytometric analysis
demonstrated that IL-12 treatment resulted in increased& Microbe 14, 387–397, October 16, 2013 ª2013 Elsevier Inc. 391
Figure 5. The NKp30 Receptor Mediated NK Fungal Cytotoxicity
(A and B) NKp30 was knocked down in YT cells, and antifungal activity was assessed against C. neoformans (strain B3501) (A) or Candida albicans (B). Data
shown are representative of three experiments.
(C–F) A rabbit polyclonal anti-NKp30 (C, D, and F) or mAb 1C01 (E) was used to block NKp30 on YT cells, and antifungal activity was assessed against
C. neoformans strain B3501, serotypeD (C), acapsulated strain CAP67 (D), strain H99, serotype A (E), andCandida albicans (F). Isotype: rabbit polyclonal antibody
(Abcam, ab27472) ormouse IgG2a (BD, 555573). Data shownare representative of three experiments. The same starting inoculumwas used (approximately 1,000
microorganisms as determined by hemocytometer count). *p < 0.05. Data are represented as mean ± SEM; NS: not significant. See also Figures S3.
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not from healthy donors (Figure 6D).
To determine whether this gain in NKp30 expression could
improve anticryptococcal activity, we assessed cryptococcal
cfu after coculturing the IL-12-treated NK cells. IL-12 signifi-
cantly augmented the ability of NK cells from HIV-infected
patients to kill C. neoformans, while there was no apparent
enhanced killing in NK cells from healthy donors (Figure 6E). To
investigate the possibility that IL-12 might enhance killing by a
mechanism independent of increased NKp30 expression, we
used an antibody to block the NKp30 receptor following
treatment with IL-12. The mAb 1C01 significantly inhibited IL-
12-enhanced killing of NK cells from HIV-infected patients
(Figure 6F), suggesting that the enhanced killing by IL-12 was
due to increased expression of NKp30. These data indicated
that the NKp30 receptor played a critical role in cryptococcal
killing by NK cells fromHIV-infected patients and that the defects
in expression and function were reversible.
DISCUSSION
It is now well established that NK cells possess microbicidal ac-
tivity against a number of divergent fungal species. In addition to
C. albicans and C. neoformans, NK cells have antifungal activity
forParacoccidioides brasiliensis andCoccidioides immitis (Jime-392 Cell Host & Microbe 14, 387–397, October 16, 2013 ª2013 Elsevnez and Murphy, 1984; Petkus and Baum, 1987). NK cells are
active against the hyphae of Aspergillus fumigatus (Bouzani
et al., 2011; Schmidt et al., 2011), and optimal host defense to
Aspergillus requires the contribution of effector NK cells (Morri-
son et al., 2003). Patients with primary hemophagocytic lympho-
histiocytosis who possess a defect in NK cell cytotoxicity are
predisposed to Candida, Aspergillus, and Fusarium spp. (Albi-
setti et al., 2004; Sung et al., 2001), and perforin knockout
mice display increased mortality and fungal burden during
infection with Histoplasma capsulatum (Zhou et al., 2001). More-
over, it has recently been reported that microbicidal lympho-
cytes are active against Pneumocystis (Kelly et al., 2013). The
diversity of these fungal species suggests that the mechanism
of NK cell microbicidal host defense extends broadly across
the pathogenic fungal kingdom.
Since the description by Janeway (1989) that NK receptors are
a primordial mechanism of immunity to infectious pathogens,
there has been speculation that NK receptors are pattern recog-
nition receptors for microbes. Previous studies demonstrated
that T cells and NK cells make direct cell conjugates with
C. neoformans (Levitz et al., 1994; Murphy et al., 1993), and
the antifungal activity wasmarkedly diminished when surface re-
ceptors on microbicidal lymphocytes were cleaved by treatment
with trypsin or bromelain (Levitz et al., 1994). Moreover, these
cells utilized a cytolytic signaling pathway involving PI3K,ier Inc.
Figure 6. NK Cells from HIV-Infected Patients Had Deficient NKp30 Expression, Aberrant NKp30-Mediated Perforin Release, and Defective
Fungal Cytotoxicity, which Were Restored by IL-12
(A) Comparison of NKp30 labeling by mAb 1C01 and anti-NKp30 Ab in NK cells from 6–7 experiments (denoted by different symbols) from paired HIV-infected
patients and healthy donors using flow cytometry (mAb 1C01 labeling, n = 6; anti-NKp30 labeling, n = 7). A paired, two-tailed t test was used to determine
statistical significance.
(B) C. neoformans antifungal activity of NK cells from HIV-infected patients and healthy subjects. Data shown are representative of three experiments.
(C) Perforin in culture media of NK cells from HIV-infected patients and healthy subjects in response to Cryptococcus assessed by ELISA. Experiments were
repeated twice with similar results.
(D) Change of NKp30 labeling onNK cells in healthy (NK [healthy]) or HIV-infected (NK [HIV]) adults after treatment with (+) andwithout () IL-12 (data aremean of 8
subjects). Values = MFIpost-IL-12 / MFIpre-IL-12.
(E) IL-12 treatment enhanced killing by NK cells fromHIV-infected patients. Purified NK cells from HIV-infected patients and healthy subjects were treated with 50
units of recombinant IL-12 before coculture with C. neoformans (strain B3501) and assessing anticryptococcal activity.
(F) mAb 1C01 blocked the IL-12-enhanced antifungal activity. NK cells from HIV-infected patients were pretreated with IL-12 before the addition of mAb 1C01.
Data shown are representative of five experiments. Isotype: mouse IgG2ak (BD, 555573) for mAb 1C01. Data are represented as mean ± SEM. *p < 0.05; NS, not
significant.
Cell Host & Microbe
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2007). Taken together, these studies implicated receptor
recognition in the direct interaction of microbicidal lymphocytes
with fungi. However, previous attempts to identify the receptor,
including pathogen recognition receptors known to bind
C. neoformans, had failed (Jones et al., 2009). Consequently,
we undertook an unbiased approach that generated a library of
mAb that could be screened to identify the receptor. It is impor-
tant to note that the current studies made use of NK cells as the
antigen, and therefore mAb were biased toward NK receptors.
The current studies showed that antibody to NKp30 was able
to abrogate killing of Cryptococcus and Candida but unable to
completely inhibit conjugate formation. This raises the possibility
that a multistep process is involved in binding and antifungal
effector activity of NK cells and that additional NK receptors
are involved. While additional NK cell receptors remain to beCell Hostidentified, the current studies implicate NKp30 as a major
receptor used by NK cells.
Our observation that NKp30 is the receptor for such
widely divergent fungi as C. albicans, an ascomycete, and
C. neoformans, a basidiomycete, raises the possibility that the
as-yet-undescribed pathogen-associated molecular pattern
(ligand) recognized by the NKp30 is sufficiently similar across
fungi and suggests that NKp30 plays an important role in fungal
host defense. NKp30 has been reported to recognize diverse
ligands, including the cytomegalovirus (CMV) pp65 tegument
protein and the Duffy binding-like domain exposed during
Plasmodium infection, but has no previously identified role in
fungal recognition (Arnon et al., 2005; Mavoungou et al., 2007).
Structurally, NKp30 ismost closely related to the CD28/B7 family
of I-type immunoglobulin receptors and possesses a hybrid
structure that consists of eight b strands but lacks the C0 and& Microbe 14, 387–397, October 16, 2013 ª2013 Elsevier Inc. 393
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of receptors comprises critical regulators of T cell activation and
tolerance, with no known role in fungal recognition. More
broadly, immunoglobulin superfamily receptors (IgSFRs) are
important in innate virus recognition and recognition of bacteria
and bacterial superantigens (Choi et al., 1990; Jameson et al.,
1988; Mendelsohn et al., 1989; Short et al., 2004). Carcinoem-
bryonic antigen-related cell adhesion molecule (CEACAM1)
and signaling lymphocytic activation molecule family member
1 (SLAMF1; CD150), both IgSFRs, function in the recognition
of several bacterial pathogens (Berger et al., 2010; Gray-Owen
and Blumberg, 2006; Kuespert et al., 2006). Although IgSFRs
have a limited role in innate recognition of higher-order mi-
crobes, studies have reported that the I-type IgSFR, ICAM-1,
recognizes Plasmodium falciparum (Berendt et al., 1989) and
that C. albicans binds to ICAM-1 (Yokomura et al., 2001). By
contrast, fungal pattern recognition receptors include C-type
lectin receptors, Toll-like receptors, integrins, scavenger recep-
tors, and hyaluronic acid receptors rather than IgSFRs. Thus, our
data suggest that NKp30, an IgSFR, is an important addition to
the fungal pattern recognition receptor family.
HIV-infected patients have dysfunctional NK cells (Alter et al.,
2005; Mavilio et al., 2003; 2005) and are susceptible to Crypto-
coccus andCandida infections.We speculated that HIV-infected
patients might also have defective NKp30-mediated antifungal
cytotoxicity. Although many studies have reported defective
NK receptor expression in HIV-infected patients (De Maria
et al., 2003; Fogli et al., 2004; Mavilio et al., 2006), we show a
functional consequence of the defect that is relevant to opportu-
nistic fungal infections and translate this to a potent therapeutic
target. Notably, HIV-infected patients secrete markedly lower
amounts of IL-12 and have aberrant IL-12 production in
response to bacterial and protozoal stimuli compared to healthy
controls (Chehimi et al., 1994; Chougnet et al., 1996; Gazzinelli
et al., 1995; Marshall et al., 1999; Mavilio et al., 2006; Meyaard
et al., 1997). Our observations that deficient NKp30 expression
leads to defective perforin release and fungal cytotoxicity and
that IL-12 can correct these defects expand our understanding
to include NK-mediated microbicidal activity in HIV-infected
and AIDS patients. If the side effects of IL-12 therapy could be
overcome, this may provide a therapeutic approach.
Together, we show that NKp30 is an NK cell fungicidal recep-
tor, that the NKp30 receptor plays a critical role in defective NK
cytotoxicity to fungi in HIV-infected patients, and that these
defects can be reversed therapeutically with IL-12.
EXPERIMENTAL PROCEDURES
Cells and Microorganisms
YT cells were maintained in complete RPMI 1640 medium supplemented
with 10% fetal calf serum (FCS), 1% penicillin-streptomycin (pen-strep), 1%
sodium pyruvate (Invitrogen, Gibco 11360), and 1% nonessential amino acids
(Invitrogen, Gibco 11140) at 37C and 5% CO2. Cryptococcus neoformans
strains B3501 (ATCC 34873), CAP67 (ATCC 52817, serotype D), and H99
(ATCC 208821, serotype A) and Candida albicans strain (ATCC 58716,
serotype A, formerly LUMC 101) were cultured in Sabouraud Dextrose Broth
(Becton Dickinson [BD], 238230). Primary NK cells from healthy donors and
HIV-infected patients were purified by using the RosetteSep Human NK Cell
Enrichment Cocktail (STEMCELL, 15065). NK cells were routinely 92%–97%
CD3CD16+CD56+. HIV-infected patients (n = 14) had CD4 counts from 140
to 663, an undetectable viral load, and were on highly active antiretroviral394 Cell Host & Microbe 14, 387–397, October 16, 2013 ª2013 Elsevtherapy (HAART), except one patient with a CD4 count of 315, viral load
151,356/ml, and not onHAARTwhen the bloodwas drawn. The Conjoint Health
Research Ethics Board of the University of Calgary, Calgary, AB, Canada
approved use of human materials.
Antibody Generation from Mice
The mouse immunization protocol was adapted from Phillips and Babcock
(1983). Briefly, BALB/c mice were injected via the intraperitoneal route on
day 1 with 53 106 YT cells and boosted two weeks later with 23 106 YT cells.
After 2 weeks, spleens from mice with a high titer of serum anti-YT cell anti-
bodies were isolated and fused with SP2/MIL6 myeloma cells.
Flow Cytometry for Competitive Binding and Conjugate Formation
Conjugate formation of NK cells withCryptococcuswas adapted from the pro-
tocol of Barber and Long (2003). Briefly, YT cells were labeled with 1.5 mM
TRITC (Invitrogen, T-490) and C. neoformans with 0.1 mM of FITC (Sigma,
3326-32-7). The TRITC-labeled YT cells (23 103) were cocultured in the pres-
ence of mAb 1C01 (1.25 mg/ml) or mouse IgG (Life Technologies, 08-6599)
Cells were incubated at 37C for 30 min and fixed using 0.5% formalin prior
to flow cytometric analysis.
Antifungal Activity Assay
YT cells (23 105) were cocultured withC. neoformans or C. albicans in 96-well
plates (Costar) at 37C for 24 hr. To test the ability of 1C01 to inhibit YT cell
killing of C. neoformans or C. albicans, YT cells were pretreated with mAb
1C01 at 37C for 30 min before Cryptococcuswas added. The control Ab con-
sisted of conditioned medium plus appropriate isotype IgG, i.e., mouse IgG
(Life Technologies, 08-6599) or mouse IgG2a, k (BD, 555573) for mAb01 and
rabbit polyclonal IgG (ab27472) for rabbit polyclonal anti-NKp30. Colony-form-
ing units (cfu) were counted after 24 hr of incubation.
Anti-Candida activity was assessed by MTS (CellTiter 96 One Solution Cell
Proliferation Assay, Promega) as per the manufacturer’s instructions. Candida
was incubated with YT cells at various effector-to-target ratios. At various
times, the YT cells were lysed with 0.03% SDS. Immediately, 10 ml of MTS
solution was added to each well and incubated at 37C for 4 hr. The absor-
bance was determined at 490 nm. All groups were determined in quadrupli-
cate, and the experiment was repeated three times with similar results.
Phosphorylation of Akt and ERK in Response to C. neoformans
YT cells were pretreated with mAb 1C01 (1.25 mg/ml) or control IgG at 37C for
30min before stimulation with or withoutC. neoformans (B3501) for 5min. Pro-
tein samples from the same experiment were resolved in 4%–12%SDS-PAGE
gels, and membranes were blocked and blotted in identical conditions. Pro-
teins were blotted with rabbit polyclonal p-Akt1/2/3 (Ser473)-R (sc-7985-R,
Santa Cruz), mouse monoclonal p-ERK (E-4; sc-7383, Santa Cruz). Condi-
tioned medium plus mouse IgG (Life Technologies, 08-6599) was used as
control for mAb 1C01.
Microscopy
For immunofluorescence labeling, YT cells (0.5 3 106) were incubated with
1.25 mg mAb 1C01, and the labeling was visualized using a goat anti-mouse
antibodyconjugatedwithAlexa555 (red) (MolecularProbes,A-21422), anti-per-
forin-FITC antibody (BD 556577, green), and phalloidin-A633 (Cy5) (Invitrogen
A22284, pseudocolored blue). Both differential interference contrast (DIC)
and fluorescent imaging were performed using Delta Vision microscopy, IX70
(AppliedPrecision)withaPlanApo603objective (1.46NA) equippedwithstack-
ing capabilities. The scoring was done blinded, and counts were taken of
contiguous fields. DIC and fluorescence images represented one deconvolved
z stack obtained using the digital deconvolution program softWoRx v3.5.1
(Applied Precision). The representative images shown were contrast enhanced
for clarity using softWoRx v3.5.1 Mouse IgG (Life Technologies, 08-6599).
NKp30 Knockdown in YT Cells by siRNA Technology
Three different siRNAs for human NKp30 (Thermo Scientific, 016894-3,
016894-4, and 016894-5) were used to knock down NKp30 in YT cells. Non-
targeting siRNA (Thermo Scientific, D-001210-02-05) was used as control.
Transfection was performed by suspending YT cells (2 3 106) in Nucleofector
Solution V in an Amaxa cuvette (Lonza, VCA-1003).ier Inc.
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Receptor-Mediated NK Cell Cytotoxicity to FungiSurface Protein Biotinylation, Immunoprecipitation, and Western
Blot
Cell surface biotinylation using Sulfo-NHS-SS-Biotin (Thermo Scientific,
89891) was performed according to the manufacturer’s instructions. Cells
were placed in lysis buffer (20 mM Tris-HCl, 1 mM EDTA, 150 mM NaCl,
1% Triton X-100, 10 mM sodium pyrophosphate [pH 7.6]) and immunoprecip-
itated with the NeutrAvidin according to the manufacturer’s instructions
(Invitrogen, 100.07D). Materials were resolved in 4%–12% SDS-PAGE gel
in reducing condition, The bands were visualized by adding secondary IRDye
800CW goat anti-mouse or IRDye 680LT goat anti-rabbit antibodies (LI-COR
Biosciences), and images were acquired using the Odyssey Imaging program
v3.0.21.
Determination of Perforin Content in YT Cells and in Culture Media
YT cells were pretreated with mAb 1C01 or Mouse IgG2a, k (BD, 555573) at
37C for 30min and cultured with or withoutC. neoformans (B3501) for various
times. Cells and culture media were collected at the same time. Perforin in YT
cells were analyzed by using western blot and flow cytometry. Perforin
released in the culture media was measured using an ELISA Kit (Abcam,
ab46115) according to the manufacturer’s instructions. Optic density readings
were performed using SpectraMax M2 & M2e Multi-Mode Microplate Reader
(Molecular Devices).
Statistical Analyses
Statistical studies were performed using GraphPad Prism v5.0. Unless other-
wise specified, one-way ANOVA followed by Bonferroni comparison tests or
unpaired t tests (two-tailed) with Welch correction were used to evaluate
differences among conditions. In all cases, p < 0.05 was considered
significant.
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